Shuford, the CDC’s chief medical officer, stepped down on Nov. 5, 2024, the day the midterm elections concluded, signalling a shake‑up in the agency’s leadership amid growing policy disputes.
President Donald Trump, speaking on a White House press conference on Oct. 15, unveiled plans to require vaccine manufacturers to split five childhood shots into separate doses. This move echoes long‑standing concerns voiced by Health Secretary Robert F. Kennedy Jr., who has repeatedly promoted unfounded vaccine‑autism links.
Shuford’s career began as Texas health commissioner, where she oversaw statewide immunization drives. She joined the CDC in April 2024, alongside former deputy surgeon general Erica Schwartz, healthcare executive Sean Slovenski, and FDA official Sara Brenner, as part of a wave of senior appointments aimed at strengthening the agency’s public health response.
An unnamed CDC insider noted that Shuford’s exit reflects deep disagreements over vaccine policy direction. “The administration’s stance on dose splitting conflicts with evidence‑based public health strategy,” the insider said, highlighting a broader rift within the agency.
The CDC will appoint a new deputy director in early December, as the administration moves to align its public health leadership with the Trump‑era vaccine agenda. This appointment will likely influence the rollout of the new dose‑splitting policy across federal and state programs.